Mirum Pharmaceuticals, Inc.MIRMNASDAQ
LOADING
|||
Year-over-year gross profit growth rate
| Period | Value |
|---|---|
| Q3 2025 | 2.98% |
| Q2 2025 | 17.84% |
| Q1 2025 | 15.57% |
| Q4 2024 | 10.15% |
| Q3 2024 | 20.68% |
| Q2 2024 | 12.17% |
| Q1 2024 | 15.40% |
| Q4 2023 | 18.77% |
| Q3 2023 | 22.20% |
| Q2 2023 | 15.27% |
| Q1 2023 | 13.70% |
| Q4 2022 | 47.73% |
| Q3 2022 | 5.94% |
| Q2 2022 | 42.91% |
| Q1 2022 | 747.61% |
| Q4 2021 | -75.30% |
| Q3 2021 | -54.55% |
| Q2 2021 | 0.00% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |